Lunger Ilaria, Fawaz Malak, Rieger Michael A
Department of Medicine, Hematology/Oncology, Goethe University Frankfurt, Frankfurt am Main, Germany.
German Cancer Consortium (DKTK), Heidelberg, Germany.
FEBS Lett. 2017 Aug;591(15):2195-2212. doi: 10.1002/1873-3468.12712. Epub 2017 Jul 2.
Hematopoietic stem cells (HSCs) are the best studied adult stem cells with enormous clinical value. Most of our knowledge about their biology relies on assays at the single HSC level. However, only the recent advances in developing new single cell technologies allowed the elucidation of the complex regulation of HSC fate decision control. This Review will focus on current attempts to investigate individual HSCs at molecular and functional levels. The advantages of these technologies leading to groundbreaking insights into hematopoiesis will be highlighted, and the challenges facing these technologies will be discussed. The importance of combining molecular and functional assays to enlighten regulatory networks of HSC fate decision control, ideally at high temporal resolution, becomes apparent for future studies.
造血干细胞(HSCs)是研究最为深入的具有巨大临床价值的成体干细胞。我们对其生物学特性的了解大多依赖于单个造血干细胞水平的检测。然而,直到最近开发新的单细胞技术取得进展,才得以阐明造血干细胞命运决定控制的复杂调控机制。本综述将聚焦于目前在分子和功能水平研究单个造血干细胞的尝试。将着重介绍这些技术所带来的对造血作用的开创性见解的优势,并讨论这些技术面临的挑战。将分子检测与功能检测相结合,以阐明造血干细胞命运决定控制的调控网络,理想情况下是在高时间分辨率下进行,这对于未来的研究具有重要意义。